Mallinckrodt spinoff to include 7 manufacturing sites in U.S. and Japan

Date Published12/18/2018
Author NameEric Palmer
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Mallinckrodt Pharmaceuticals
Parent companyMallinckrodt Pharmaceuticals
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2018
Year reshoring implemented or to be implemented:2019
Capital investment ($):20
Country(ies) from which reshored:Ireland
City reshored to:St. Louis
State(s) reshored to:MO
If relevant, work nearshored to:-
Product(s) reshoredacetaminophen and specialty drugs
What domestic positive factors made reshoring more attractive?Customization/Flexibility
Find Reshoring Articles